Envestnet Asset Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,573
| Closed | -$717K | – | 3214 |
|
|
2019
Q3 | $717K | Sell |
10,573
-272
| -3% | -$18.7K | ﹤0.01% | 2164 |
|
|
2019
Q2 | $631K | Buy |
10,845
+1,037
| +11% | +$61.4K | ﹤0.01% | 2248 |
|
|
2019
Q1 | $687K | Buy |
9,808
+4,826
| +97% | +$358K | ﹤0.01% | 2138 |
|
|
2018
Q4 | $321K | Buy |
+4,982
| New | +$349K | ﹤0.01% | 2391 |
|
|
2018
Q3 | – | Sell |
-885
| Closed | -$45K | – | 3006 |
|
|
2018
Q2 | $45K | Buy |
885
+53
| +6% | +$2.1K | ﹤0.01% | 2240 |
|
|
2018
Q1 | $26K | Sell |
832
-9,057
| -92% | -$300K | ﹤0.01% | 2316 |
|
|
2017
Q4 | $338K | Buy |
9,889
+292
| +3% | +$9.31K | ﹤0.01% | 1650 |
|
|
2017
Q3 | $308K | Buy |
9,597
+593
| +7% | +$18.7K | ﹤0.01% | 1661 |
|
|
2017
Q2 | $292K | Buy |
9,004
+722
| +9% | +$22.9K | ﹤0.01% | 1733 |
|
|
2017
Q1 | $259K | Buy |
8,282
+993
| +14% | +$29.4K | ﹤0.01% | 1813 |
|
|
2016
Q4 | $214K | Sell |
7,289
-805
| -10% | -$24.5K | ﹤0.01% | 1866 |
|
|
2016
Q3 | $234K | Buy |
8,094
+5,547
| +218% | +$155K | ﹤0.01% | 1951 |
|
|
2016
Q2 | $66K | Buy |
2,547
+1,439
| +130% | +$38.2K | ﹤0.01% | 2613 |
|
|
2016
Q1 | $27K | Sell |
1,108
-895
| -45% | -$24.6K | ﹤0.01% | 2907 |
|
|
2015
Q4 | $71K | Sell |
2,003
-587
| -23% | -$15.7K | ﹤0.01% | 2526 |
|
|
2015
Q3 | $55K | Buy |
+2,590
| New | +$66.7K | ﹤0.01% | 2612 |
|
|
2015
Q1 | – | Sell |
-1,259
| Closed | -$40K | – | 2539 |
|
|
2014
Q4 | $40K | Sell |
1,259
-355
| -22% | -$11.6K | ﹤0.01% | 1500 |
|
|
2014
Q3 | $46K | Buy |
1,614
+66
| +4% | +$1.84K | ﹤0.01% | 1556 |
|
|
2014
Q2 | $42K | Buy |
+1,548
| New | +$41.2K | ﹤0.01% | 1505 |
|
|
2014
Q1 | – | Sell |
-30
| Closed | -$1K | – | 2678 |
|
|
2013
Q4 | $1K | Buy |
+30
| New | +$952 | ﹤0.01% | 2407 |
|
Envestnet Asset Management's GHDX Position: Q4 2019 in Review
Envestnet Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 10,573 shares — an estimated $717K sold.
Envestnet Asset Management first reported a position in GHDX in Q4 2013 and held it in 20 quarters. The position peaked at $717K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Envestnet Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Envestnet Asset Management sold 10,573 Genomic Health, Inc. shares in Q4 2019, an estimated $717K.
- Envestnet Asset Management first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 20 quarters.
- Envestnet Asset Management's Genomic Health, Inc. position peaked at $717K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Envestnet Asset Management's 13F filing for Q4 2019, filed 11 Feb 2020.